SC
RCUS icon

Steven Cohen’s Arcus Biosciences RCUS Stock Holding History

Steven Cohen’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-129,273
Closed -$2.79M – 4484
2026
Q1 		$2.79M Sell
129,273
-3,150,727
-96% -$68M ﹤0.01% 2099
2025
Q4 		$78.2M Sell
3,280,000
-1,052,479
-24% -$21.5M 0.09% 250
2025
Q3 		$58.9M Sell
4,332,479
-1,634,185
-27% -$17M 0.1% 229
2025
Q2 		$48.6M Buy
5,966,664
+3,099,567
+108% +$26.5M 0.1% 257
2025
Q1 		$22.5M Buy
2,867,097
+870,818
+44% +$10.1M 0.05% 421
2024
Q4 		$29.7M Sell
1,996,279
-440,794
-18% -$7.2M 0.07% 341
2024
Q3 		$37.3M Buy
2,437,073
+603,222
+33% +$9.51M 0.09% 251
2024
Q2 		$27.9M Sell
1,833,851
-81,081
-4% -$1.31M 0.07% 323
2024
Q1 		$36.2M Buy
1,914,932
+1,146,182
+149% +$19.8M 0.09% 279
2023
Q4 		$14.7M Buy
768,750
+764,293
+17,148% +$12.2M 0.04% 549
2023
Q3 		$80K Sell
4,457
-705,184
-99% -$14.2M ﹤0.01% 2027
2023
Q2 		$14.4M Buy
+709,641
New +$13.5M 0.04% 481
2023
Q1 		– Sell
-425,301
Closed -$8.8M – 2494
2022
Q4 		$8.8M Buy
425,301
+367,467
+635% +$10.1M 0.03% 594
2022
Q3 		$1.51M Buy
+57,834
New +$1.53M 0.01% 988
2021
Q2 		– Sell
-62,926
Closed -$1.77M – 1136
2021
Q1 		$1.77M Buy
+62,926
New +$2.19M 0.01% 744
2020
Q4 		– Sell
-194,001
Closed -$3.33M – 1097
2020
Q3 		$3.33M Buy
+194,001
New +$4.33M 0.02% 635

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Steven Cohen's RCUS Position: Q2 2026 in Review

Steven Cohen sold out of Arcus Biosciences (RCUS) in Q2 2026, closing a stake of 129,273 shares — an estimated $2.79M sold.

Steven Cohen first reported a position in RCUS in Q3 2020 and held it in 16 quarters. The position peaked at $78.2M in Q4 2025. 228 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Steven Cohen reported no remaining Arcus Biosciences position as of Q2 2026 after selling out during the quarter.
  • Steven Cohen sold 129,273 Arcus Biosciences shares in Q2 2026, an estimated $2.79M.
  • Steven Cohen first reported a position in Arcus Biosciences in Q3 2020 and held it in 16 quarters.
  • Steven Cohen's Arcus Biosciences position peaked at $78.2M in Q4 2025.
  • 228 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Point72 Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.